Mode
Text Size
Log in / Sign up

Histone lactylation links glycolysis to salivary gland fibrosis in Sjogren's diseaseScientists Link Cell Metabolism to Sjogren's Gland Damage

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Interpret histone lactylation as a hypothesis-generating mechanism, not a clinical target.

This is a systematic review examining the role of histone lactylation in Sjogren's disease (SjD). The authors synthesize findings from other fields, including immunometabolism, epigenetic rewiring, and tissue fibrogenesis, because direct evidence in SjD is currently lacking.

The review proposes that histone lactylation serves as a pivotal metabolic-epigenetic bridge linking glycolysis to salivary gland fibrosis. It highlights potential downstream mechanisms such as immune cell polarization, epithelial-mesenchymal transition, and myofibroblast activation.

No primary outcome, comparator, or effect sizes were reported. The authors explicitly note that direct evidence in SjD is lacking, and the review draws on evidence from other disease contexts.

Safety data, including adverse events, serious adverse events, discontinuations, and tolerability, were not reported. Funding sources and conflicts of interest were also not reported.

The authors suggest potential for novel biomarkers and therapeutic interventions, but these remain speculative given the absence of direct SjD evidence. Clinicians should interpret these mechanistic hypotheses cautiously and recognize that they do not yet support changes to clinical practice.

How this fits prior evidence

This review extends prior coverage of Sjogren's disease mechanisms, including a narrative review on TLR7 and TLR9 signaling and a review on renal involvement, by proposing histone lactylation as a metabolic-epigenetic link to fibrosis. It also aligns with a prior review on FGF/FGFR signaling as a source of mechanistic targets in autoimmune rheumatic diseases. Unlike the case report on autoimmune nodopathy and nephrotic syndrome, this review is not patient-specific. It addresses a gap in mechanistic understanding of salivary gland fibrosis, but direct evidence in SjD remains lacking.

A new review looks at how a cell process called histone lactylation might connect sugar metabolism to salivary gland damage in Sjogren's disease. Histone lactylation is a way cells attach chemical tags to proteins that package DNA, which can change how genes behave. The review suggests this process may act as a bridge between glycolysis, the way cells break down sugar, and the scarring of salivary glands.

The authors point to three areas where this process may play a role: how immune cells polarize, how epithelial cells change into mesenchymal cells, and how myofibroblasts become activated. These are all processes tied to tissue scarring and inflammation.

The review does not report a study population, sample size, or follow-up. It also does not report safety data, adverse events, or tolerability. The main limitation is that direct evidence in Sjogren's disease is currently lacking. The authors drew on findings from other fields, including immunometabolism, epigenetic rewiring, and tissue fibrogenesis.

The takeaway is that histone lactylation is a potential area for future biomarkers and treatments, not a proven cause or a current therapy. People with Sjogren's disease should talk with their doctor about any treatment decisions.

What this means for you:
Early review suggests histone lactylation may link sugar metabolism to salivary gland damage in Sjogren's, but direct evidence is lacking.

Common questions

What is histone lactylation?

Histone lactylation is a process where cells attach chemical tags to proteins that package DNA. This can change how genes are turned on or off. The review suggests it may connect glycolysis, the breakdown of sugar, to salivary gland scarring in Sjogren's disease. However, the review does not report direct evidence in Sjogren's patients.

Does this mean there is a new treatment for Sjogren's disease?

No. The review only suggests that histone lactylation could be a target for future biomarkers and treatments. It does not report any tested treatment, patient population, or safety data. Any treatment decisions should be discussed with a doctor.

Is this finding based on studies in people with Sjogren's?

No. The review states that direct evidence in Sjogren's disease is currently lacking. The authors synthesized findings from other fields, including immunometabolism, epigenetic rewiring, and tissue fibrogenesis. This means the link is a hypothesis, not a proven cause.

What are the side effects or safety concerns?

The review does not report any adverse events, serious adverse events, discontinuations, or tolerability data. Because no treatment was tested in this review, there are no safety results to share. Anyone considering treatment should speak with their doctor.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedSep 2026
View Original Abstract ↓
Sjögren’s disease (SjD) is a chronic, systemic autoimmune disorder characterized by lymphocytic infiltration and progressive loss of exocrine gland function. Despite advances in understanding its immunopathogenesis, the molecular mechanisms governing the transition from inflammation to irreversible salivary gland fibrosis remain obscure. Emerging evidence suggests that the crosstalk between metabolic reprogramming and epigenetic modifications profoundly shapes the local inflammatory microenvironment and accelerates disease progression. Histone lactylation, a recently discovered lactate-derived epigenetic mark, directly couples enhanced glycolytic activity and lactate accumulation with transcriptional regulation, thereby serving as a pivotal metabolic-epigenetic bridge. This review systematically examines the potential role of histone lactylation in SjD salivary gland pathology. We delineate the enzymatic machinery of lactylation, the metabolic origins of lactate within the inflamed microenvironment, and the functional implications for immune cell polarization, epithelial-mesenchymal transition, and myofibroblast activation. While direct evidence in SjD is currently lacking, we synthesize findings by integrating immunometabolism, epigenetic rewiring, and tissue fibrogenesis, we aim to establish histone lactylation as a transformative framework for understanding SjD pathogenesis and highlight its translational potential for novel biomarkers and therapeutic interventions.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.